Impaired cerebral oxygenation and exercise tolerance in patients with severe obstructive sleep apnoea syndrome
M. MARILLIER (Grenoble, France), M. Gruet (Grenoble, France), S. Baillieul (Grenoble, France), B. Wuyam (Grenoble, France), R. Tamisier (Grenoble, France), P. Levy (Grenoble, France), J. Pepin (Grenoble, France), S. Verges (Grenoble, France)
Source: International Congress 2018 – Mechanisms that underlie exercise limitation in various respiratory diseases
Disease area: Sleep and breathing disorders
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. MARILLIER (Grenoble, France), M. Gruet (Grenoble, France), S. Baillieul (Grenoble, France), B. Wuyam (Grenoble, France), R. Tamisier (Grenoble, France), P. Levy (Grenoble, France), J. Pepin (Grenoble, France), S. Verges (Grenoble, France). Impaired cerebral oxygenation and exercise tolerance in patients with severe obstructive sleep apnoea syndrome. 480
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
The impact of obstructive sleep apnoea syndrome on endothelial function in patients with moderate and severe hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 39s Year: 2005
Cardiopulmonary exercise response in children with obstructive sleep apnea syndrome Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA Year: 2012
Impact of CPAP-therapy on cardiac structure and function in patients with obstructive sleep apnea syndrome and coprevalent arterial hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 817s Year: 2006
Acetazolamide improves central sleep apnea in patients with obstructive sleep apnea syndrome at altitude Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea Year: 2009
Myocardial alterations in asymptomatic patients with obstructive sleep apnea syndrome Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities Year: 2017
Metabolic syndrome, systemic inflammation and oxidative stress in patients with severe obstructive sleep apnea: effects of CPAP Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008
A comparison of pulmonary function, functional exercise capacity and sleep quality in patients with chronic obstructive pulmonary disease and obstructive sleep apnea syndrome Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation Year: 2012
Inspiratory muscle dysfunction in patients with severe obstructive sleep apnoea Source: Eur Respir J 2010; 35: 373-380 Year: 2010
Prevalance of daytime hypercapnia in patients with obstructive sleep apnoea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 574s Year: 2002
Vasoconstriction during the night in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 419s Year: 2006
Sympathetic activity at rest and during exercise in metabolic syndrome subjects with and without obstructive sleep apnea Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea Year: 2008
Metabolic syndrome in moderate to severe obstructive sleep apnea? Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification Year: 2020
Unrecognised systemic hypertension in patients with obstructive sleep apnoea Source: Eur Respir J 2006; 28: Suppl. 50, 643s Year: 2006
Nocturnal intermitent hypoxemia in patients with pulmonary hypertension and sleep apnea hypopnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 657s Year: 2006
Arterial hypertension in patients with obstructive sleep apnoea and overlap syndrome Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep Year: 2009
Nocturnal hypoxia as an additional factor of functional kidney damage in patients with obstructive sleep apnoea syndrome Source: Annual Congress 2008 - Weight control and comorbidity in obstructive sleep apnoea Year: 2008
Impaired glucose tolerance and other cardiovascular risk factors in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009
Glucose metabolism abnormalities in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012
Correlation between intermittent nocturnal hypercapnia and depressive symptoms in patients with obstructive sleep apnea syndrome Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity Year: 2011
Respiratory muscle function in patients with obstructive sleep apnoea syndrome Source: Eur Respir J 2001; 18: Suppl. 33, 419s Year: 2001